Senseonics (NYSE:SENS) Shares Down 5.7% - What's Next?

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) traded down 5.7% during trading on Friday . The company traded as low as $1.24 and last traded at $1.24. 5,487,003 shares were traded during mid-day trading, a decline of 67% from the average session volume of 16,734,430 shares. The stock had previously closed at $1.31.

Analyst Upgrades and Downgrades

SENS has been the subject of a number of recent research reports. HC Wainwright reaffirmed a "buy" rating and set a $2.00 price target on shares of Senseonics in a research note on Friday, November 15th. StockNews.com started coverage on shares of Senseonics in a research report on Thursday, December 26th. They set a "sell" rating on the stock.

Senseonics Price Performance

The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The stock has a market capitalization of $672.72 million, a P/E ratio of -8.69 and a beta of 0.69. The stock's fifty day moving average is $0.75 and its 200-day moving average is $0.49.

Insider Buying and Selling

In other news, CEO Timothy T. Goodnow bought 315,000 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were acquired at an average cost of $0.31 per share, for a total transaction of $97,650.00. Following the purchase, the chief executive officer now owns 11,310,355 shares of the company's stock, valued at $3,506,210.05. This represents a 2.86 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Frederick T. Sullivan bought 124,933 shares of the business's stock in a transaction on Thursday, December 12th. The shares were purchased at an average cost of $0.38 per share, with a total value of $47,474.54. Following the transaction, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. The trade was a 5.31 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.60% of the company's stock.

Institutional Investors Weigh In On Senseonics

Hedge funds and other institutional investors have recently made changes to their positions in the business. FMR LLC boosted its stake in Senseonics by 48,267.2% during the 3rd quarter. FMR LLC now owns 168,318 shares of the company's stock valued at $59,000 after purchasing an additional 167,970 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company's stock worth $2,042,000 after buying an additional 179,103 shares during the last quarter. GSA Capital Partners LLP bought a new stake in shares of Senseonics in the third quarter valued at approximately $117,000. Ridgecrest Wealth Partners LLC acquired a new stake in shares of Senseonics in the fourth quarter worth $60,000. Finally, Symmetry Partners LLC bought a new position in Senseonics during the third quarter worth $164,000. 12.36% of the stock is owned by institutional investors and hedge funds.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.